With the numbers of Justices of the Peace (JPs) being commissioned in Western Australia dwindling, UWA graduates are urged to broaden their community service and volunteering experience by becoming a JP.
UWA graduate Malcolm Collier JP – who is Registrar of the Royal Association of Justices of Western Australia – said that, since January 2018, there had only been 55 JPs commissioned in WA.
“This barely covers the loss of JPs caused by change of personal circumstances, age and infirmity,” Mr Collier said.
Convocation’s subscribing members have, for many years, had access to the benefit of discounted Library Membership. Access to the Library print collections and online resources was a valuable benefit to Convocation’s members who supported Convocation through the subscription.
The money raised by subscriptions help fund faculty prizes, postgraduate research travel awards, cultural and sporting awards, and maintains Convocation’s activities on campus. Your subscription also supports the development of services for graduates.
Warden of Convocation Doug McGhie successfully completed the Ride to Conquer Cancer in early October. Each day saw the 800 plus cyclists pedalling into stiff sea breezes, and on Sunday into 70 km/h headwinds along the Warnbro Sound coast.
The Saturday evening in Mandurah was special as the head of the Harry Perkins Institute, Professor Peter Leedman, introduced top fundraisers and some particularly brave and inspirational cyclists, some of who were completing the challenge for their seventh time.
A student who joined the University Dramatic Society (UDS) soon after arriving at The University of Western Australia has gone on to win Convocation’s highest honour for her long service and huge contribution to the theatre.
A student from The University of Western Australia is undertaking innovative research which could have important benefits for cancer patients.
Rachael Zemek, who is in the fourth year of a Doctor of Philosophy, has identified the immunological pathways responsible for a successful anti-tumour immune response, which may then be targeted to improve response rates.